Daniel Moreira
St. Jude Children's Research Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Daniel Moreira as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 22:28 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT06528691 · Entrectinib as a Single Agent in Upfront Therapy for Children <3 Years of Age With NTRK1/2/3 or ROS1-FUSED CNS TumorsSt. Jude Children's Research Hospital · recruiting · High Grade Glioma, CNS Tumor · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 22:28 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 22:28 UTC. The ranking covers the 200 most relevant of 51 PubMed records, and a shared surname and initials can bring in a namesake. All 51 on PubMed
- 117 citationsRCR 3.9
- Obesity increases the risk for high-grade prostate cancer: results from the REDUCE study.Cancer Epidemiol Biomarkers Prev · 201496 citationsRCR 2.9
- Aspirin, NSAIDs, and risk of prostate cancer: results from the REDUCE study.Clin Cancer Res · 201592 citationsRCR 2.9
- Serum cholesterol and risk of high-grade prostate cancer: results from the REDUCE study.Prostate Cancer Prostatic Dis · 201888 citationsRCR 3.4
- 6-Month Outcomes in Patients With Implantable Cardioverter-Defibrillators Undergoing Renal Sympathetic Denervation for the Treatment of Refractory Ventricular Arrhythmias.JACC Cardiovasc Interv · 201574 citationsRCR 3.0
- 59 citationsRCR 1.8
- 55 citationsRCR 2.4
- Obesity is associated with increased prostate growth and attenuated prostate volume reduction by dutasteride.Eur Urol · 201350 citationsRCR 2.0
- Statin use and risk of prostate cancer and high-grade prostate cancer: results from the REDUCE study.Prostate Cancer Prostatic Dis · 201349 citationsRCR 1.3
- 45 citationsRCR 0.9